A Meta-analysis of the Use of Polypill for Secondary Prevention of Atherosclerotic Cardiovascular Disease

Overview of attention for article published in American journal of therapeutics (Print), November 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 11 X users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 12,703 followers.

RT @al_abdouh: Check out our 📝 presented #ACC2023 and concurrently publ. #AJT: Polypill for secondary prevention of ASCVD: ⬇️ MACE ⬇️ MI @…

RT @al_abdouh: Check out our 📝 presented #ACC2023 and concurrently publ. #AJT: Polypill for secondary prevention of ASCVD: ⬇️ MACE ⬇️ MI @…

RT @al_abdouh: Check out our 📝 presented #ACC2023 and concurrently publ. #AJT: Polypill for secondary prevention of ASCVD: ⬇️ MACE ⬇️ MI @…

RT @al_abdouh: Check out our 📝 presented #ACC2023 and concurrently publ. #AJT: Polypill for secondary prevention of ASCVD: ⬇️ MACE ⬇️ MI @…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.

Login to access the Sentiment Analysis related to this output.